Corticosteroid dose escalation in non-ICU COVID-19 patients with worsening lung lesions reduces lesion severity without improving clinical outcomes
Drug Discoveries & Therapeutics · 2024
DOI: 10.5582/ddt.2024.01078 ↗Kurz gefasst
Fachartikel in der Zeitschrift Drug Discoveries & Therapeutics, 2024. Verfasst von Qingqing Wang und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Infectious Diseases, Zhongshan Hospital, Fudan University, Shanghai, China. Hauptthemen laut MEDLINE: COVID-19 Drug Treatment, Methylprednisolone, Lung, Adrenal Cortex Hormones. Die Arbeit nennt 35 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Infectious Diseases, Zhongshan Hospital, Fudan University, Shanghai, China.
Zitieren
APA
Wang, Q., Miao, Q., Ma, Y., Su, Y., Pan, J., & Hu, B. (2024). Corticosteroid dose escalation in non-ICU COVID-19 patients with worsening lung lesions reduces lesion severity without improving clinical outcomes. Drug Discoveries & Therapeutics. https://doi.org/10.5582/ddt.2024.01078
Vancouver
Wang Q, Miao Q, Ma Y, Su Y, Pan J, Hu B. Corticosteroid dose escalation in non-ICU COVID-19 patients with worsening lung lesions reduces lesion severity without improving clinical outcomes. Drug Discoveries & Therapeutics. 2024. doi:10.5582/ddt.2024.01078
BibTeX
@article{Wang2024,
author = {Wang, Qingqing and Miao, Qing and Ma, Yuyan and Su, Yi and Pan, Jue and Hu, Bijie},
title = {Corticosteroid dose escalation in non-ICU COVID-19 patients with worsening lung lesions reduces lesion severity without improving clinical outcomes},
journal = {Drug Discoveries & Therapeutics},
year = {2024},
doi = {10.5582/ddt.2024.01078}
}
EUVIMED